profit from every IDR 100 of sales.
IDR 0IDR 100
PT Sarana Meditama Metropolitan Tbk
IDR 236.00+2.61% today
-42.2% in 1 year
1-year low IDR 226.001-year high IDR 428.00
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay IDR 134.69 for every IDR 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
PT Sarana Meditama Metropolitan Tbk vs. similar companies
PT Sarana Meditama Metropolitan Tbk grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from IDR 100 of sales | Sales growth a year | Price per IDR 1 of profit |
|---|---|---|---|
| PT Sarana Meditama Metropolitan Tbk | 134.7× · Very expensive | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads PT Sarana Meditama Metropolitan Tbk's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 134.7×
- –
- 1.49
- 1.3×
- 2.2×
- –
- –
- -0.2%
- 0.7%
- –
Profitability
- 29.7%
- 6.2%
- 1.6%
- –
- 2.1%
- 1.6%
- –
- –
- –
- –
Growth
- +10.1%
- +90.4%
- –
- –
- +0.1%
Financial health
- 4.0×
- 0.26
- –
- 1.8×
- 0.53
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 36%of 963
Bottom 39%of 894
Bottom 5%of 632
Bottom 49%of 908
Bottom 35%of 991
News
The Same $10,000 in Nvidia and Palantir Could Produce Very Different Results by 2030Yahoo Finance · Nov 13, 2026'There's no question about it': Warren Buffett and Bill Gates reveal the same 1-word secret to successYahoo Finance · Nov 8, 2026American Healthcare REIT forecasts $2.23-$2.26 2026 NFFO per share as same-store NOI growth target rises to 12%-14%Seeking Alpha · Nov 6, 2026Planet Fitness raises 2026 outlook to 1.5%-2% same-club sales growth while targeting 190-195 new club openingsSeeking Alpha · Nov 5, 2026UDR signals 80-100 bps 2027 same-store revenue earn-in as $2B Apollo JV closesSeeking Alpha · Nov 3, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
25No pass
Benjamin Graham
46No pass
Philip Fisher
34No pass
Peter Lynch
69Pass
Joel Greenblatt
1No pass
Charlie Munger
14No pass
Terry Smith
10No pass
Questions about PT Sarana Meditama Metropolitan Tbk
Is PT Sarana Meditama Metropolitan Tbk a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the PT Sarana Meditama Metropolitan Tbk AI analysis
What does PT Sarana Meditama Metropolitan Tbk do?
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. It is in Medical Care Facilities.
Is PT Sarana Meditama Metropolitan Tbk stock halal?
Yes. PT Sarana Meditama Metropolitan Tbk passes our halal screen: its business is permitted and its debt is 24% of its market value, under the 30% limit. How we check
How has PT Sarana Meditama Metropolitan Tbk stock done over the past year?
Down 42.2% over the past twelve months, to IDR 236.00. It traded between IDR 226.00 and IDR 428.00 and is 44.9% below its high.
Who are PT Sarana Meditama Metropolitan Tbk's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with PT Sarana Meditama Metropolitan Tbk's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.